TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
7
Total Principal
67.3M
Shares change
-444K
Total reported value, excl. options
$59.9M
Value change
+$123K
Put/Call ratio
0
Number of buys
2
Number of sells
-1
Price
$0.88
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.